Molecular Breast Imaging
Molecular Breast Imaging is a medical procedure with 12 clinical trials. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Molecular Breast Imaging (MBI)-Guided Biopsy
Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions
Molecular Breast Imaging in Screening Breast Cancer
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Molecular Breast Imaging in Women With Atypia and LCIS
Clinical Trials (12)
Molecular Breast Imaging (MBI)-Guided Biopsy
Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions
Molecular Breast Imaging in Screening Breast Cancer
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Molecular Breast Imaging in Women With Atypia and LCIS
Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up
Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge
New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer
All 12 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 12